Greptile, a San Francisco, CA-based platform that can search and understand complex codebases in natural language, raised $4 million in seed funding. Investors The round was led by Initialized Capital, with participation from various prominent industry angels. Initialized Capital is a San Francisco and New York-based early-stage venture capital firm …

BranchLab, a New York-based data science company developing advanced AI software that enables healthcare brands to reach the right consumers, closed a seed funding round. Investors The round was led by Newark venture partners (nvp), with participation from Aperiam and several other strategic investors. Founded in 2015, newark venture partners …

Tektonic AI, a Seattle, WA-based company focused on developing Generative AI (GenAI) agents for automating enterprise processes, secured $10 million in funding. Investors The round was led by Madrona and Point72 Ventures. Madrona is a seed, early-stage, and acceleration-stage investor and partner for founders. Investing for over 25 years in …

Cube AI, a France-based company specializing in AI solutions for logistics, raised $2.5 million in pre-seed funding. Investors The round was led by VentureFriends, with notable contributions from investors including K5 Global, Olivier Pomel (Datadog), Florian Douetteau (Dataiku), and others. Founded in 2016, VentureFriends is an Athens-based investment firm that …

Bem, a San Francisco, CA-based AI data interface company, raised $3.7 million in seed funding. Investors The round was led by Uncork Capital, with significant contributions from Kevin Mahaffey, Roar Ventures, and key angel investors, including Garry Tan. Uncork Capital is a seed-stage venture capital firm that focuses on SaaS, …

Envisagenics, a New York-based biotechnology company leveraging AI for RNA splicing therapeutics, has secured a Series B funding round. Investors Existing investors Third Kind Venture Capital, Empire State Development, and Red Cell Partners, alongside new strategic investor Bristol Myers Squibb (NYSE: BMY) participated in the round. Envisagenics Use of Funds …

Testsigma, a San Francisco, California-based AI-powered, low-code test automation platform, raised $8.2 million in the funding round. In conjunction with the funding announcement, the company unveiled new GenAI capabilities to enhance its low-code platform. Investors The round was led by MassMutual Ventures, with participation from existing investors Accel, Strive, and …